Integrative analysis of VB10.16 and atezolizumab in advanced HPV16-positive cervical cancer: Linking biomarker insights to clinical outcomes.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Oslo University Hospital, University of Oslo, Fakultní nemocnice Bulovka, Ghent University Hospital, Cliniques Universitaires Saint-Luc, University Hospital Kralovske Vinohrady, University Medical Center Hamburg-Eppendorf, University Medical Centre Mannheim, Technische Universität Dresden, University of Augsburg, Medizinische Hochschule Hannover
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4410813581
